PPARG and breast cancer: Ligand activated PPARγ is reported to inhibit invasion and metastasis of breast cancer cells and induce G1/S arrest by upregulation of p21WAF1/Cip1or p27Kip1, and downregulation of cyclin D1 [11–13].